News | Radiation Therapy | May 20, 2016

ASTRO Announces Highlights of 2016 Annual Meeting

Keynote speakers to include former HHS Secretary Sebelius, Delta Airlines safety executive and Massachusetts General Hospital physicians group CEO

May 20, 2016 — Registration opened this week for the American Society for Radiation Oncology’s (ASTRO) 58th Annual Meeting, Sept. 25-28 at the Boston Convention and Exhibition Center.

This year’s meeting will feature a record number of abstracts, scientific and educational presentations on radiation oncology clinical trials, and research and keynote addresses from former U.S. Secretary of Health and Human Services Kathleen Sebelius, the current chair and CEO of the Massachusetts General Physicians Organization, and a top safety executive from Delta Air Lines.

The meeting is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team.

Led by ASTRO President David C. Beyer, M.D., FASTRO, the 2016 meeting is organized around the theme, “Enhancing Value, Improving Outcomes,” echoing growing calls from policy makers, physicians and patients for value-based healthcare. “The goal of ASTRO’s 2016 Annual Meeting is to highlight the latest scientific and technological advances while emphasizing the importance of radiation oncology in providing value to cancer patients through cure and palliation,” said Beyer.

Three keynote addresses will examine various aspects of value in healthcare, such as safety, quality and access. Keynote speakers include:

  • Kathleen Sebelius, former U.S. Secretary of Health and Human Services;
  • Thomas James Lynch Jr., M.D., chair and chief executive officer, Massachusetts General Physicians Organization; and
  • Jason Ragogna, general manager, SMS and safety alliances, corporate safety, security and compliance, Delta Air Lines Inc.

The Presidential Symposium, “Prostate Cancer: Defining Value and Delivering It,” will feature Louis Potters, M.D., FASTRO, and Jeff M. Michalski, M.D., FASTRO, to highlight recent practice-changing landmark studies and current developments in the value-based care for prostate cancer.

Concurrent with the scientific and educational program, more than 200 exhibitors will demonstrate the latest cutting-edge technology and medical device innovations for radiation oncology.

For more information: www.astro.org

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more